Spectrum Management Group, LLC Amgen Inc Transaction History

Spectrum Management Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $2.7 Million - $3.14 Million	-12,147 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $1.41 Million - $1.68 Million	-6,530 Reduced 34.96%	12,147 $2.79 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $340,711 - $378,899	1,452 Added 8.43%	18,677 $4.75 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $47,276 - $58,014	239 Added 1.41%	17,225 $4.06 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $2.39 Million - $3.17 Million	13,110 Added 338.24%	16,986 $3.44 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $56,763 - $72,960	300 Added 8.39%	3,876 $934,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $33,951 - $40,680	-195 Reduced 5.17%	3,576 $692,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $1.44 Million - $1.69 Million	-8,651 Reduced 69.64%	3,771 $695,000
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $2.24 Million - $2.53 Million	12,406 Added 77537.5%	12,422 $2.36 Million
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $2,656 - $2,984	16 New	16 $3,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Spectrum Management Group, LLC with notifications on news.